MDL Track
MDL 3029
D. Mass.
Covidien/Parietex hernia mesh
2,348 pending
Medical Device · claims involving Covidien and Parietex hernia mesh failures, adhesion, migration, and revision surgery
Defendant
Covidien LP
MDL / Track
MDL 3029
D. Mass.
Judge
Judge Patti B. Saris
Plaintiffs
~2,369 pending (2,348 per JPML's March 2, 2026 report, plus ~21 new filings tracked since)
Bellwether / Trial
Settlement Status
Track litigations for free. Save this matter, capture notes, and monitor live signals.
Case overview
claims involving Covidien and Parietex hernia mesh failures, adhesion, migration, and revision surgery
Case Management Orders
Litigation status
MDL 3029 entered active bellwether phase after an $88 million plaintiff verdict in Patterson v. Covidien, No. 1:22-cv-10153 (D. Mass. Aug. 4, 2026). Judge Patti B. Saris denied Covidien's summary judgment motion on failure-to-warn, negligence, misrepresentation, fraudulent concealment, breach of implied warranty, and punitive damages claims before trial. The court adopted stipulated protective orders and plaintiff fact sheet instructions on Aug. 10, 2026.
MDL Track
MDL 3029
D. Mass.
Covidien/Parietex hernia mesh
2,348 pending
State Court Activity
6,000+ cases pending in state courts nationwide
MDL 3029 Leadership
Plaintiff Leadership
Plaintiffs' Lead Counsel
Plaintiff
Defense Leadership
Defense National Counsel
Jessica Wilson
DLA Piper
Geographic exposure
Approximately 8,400 total cases: 2,400 federal MDL 3029 claims (D. Mass.) plus 6,000+ state court cases nationwide. Products: Parietex, Symbotex, ProGrip, Permacol. Core defect theory: porcine collagen barrier degrades within days rather than advertised 30-day resorption window, exposing polyester mesh to bowel and causing adhesions, fistulas, obstructions. No global settlement reached; active intake window open with bellwether trial underway.
MDL 3029 transferee district with approximately 2,400 pending federal claims before Judge Patti B. Saris. First bellwether trial Patterson v. Covidien (1:22-cv-10153-PBS) commenced July 13, 2026. State court concentration: over 6,000 additional cases pending nationwide, majority filed in Massachusetts as Covidien LP's home state per J.P.M.L. 2020 centralization order (481 F.Supp.3d 1348).
Plaintiff Larry Patterson, first bellwether plaintiff, implanted with Symbotex Composite Mesh in 2017. Bowel obstruction and small bowel resection. Trial venue: D. Mass. MDL 3029.
Historical exposure site: Robert Avendt implanted with Parietex synthetic mesh August 2008, followed by Permacol biologic mesh December 2008. Chronic non-healing wound, infection, mesh removal with bowel dissection. Avendt v. Covidien Inc., 262 F.Supp.3d 493 (E.D. Mich. 2017).
Covidien manufacturing/complaint handling facility. 2012 FDA inspection report identified deficiencies in adverse event reporting. Cited in Patterson bellwether Daubert proceedings (Dkt. 54-30). Facility predated Symbotex 510(k) clearance in 2013.
One of nine original districts with filed actions at MDL 3029 formation. Plaintiffs did not oppose centralization to D. Mass. per J.P.M.L. 2020 order.
One of nine original districts with filed actions at MDL 3029 formation. Plaintiffs did not oppose centralization to D. Mass. per J.P.M.L. 2020 order.
One of nine original districts with filed actions at MDL 3029 formation per J.P.M.L. 2020 centralization order.
One of nine original districts with filed actions at MDL 3029 formation per J.P.M.L. 2020 centralization order.
One of nine original districts with filed actions at MDL 3029 formation per J.P.M.L. 2020 centralization order.
One of nine original districts with filed actions at MDL 3029 formation. Plaintiffs filed joinder opposing centralization to S.D.N.Y., advocating D. Mass. instead per J.P.M.L. 2020 order.
Key defendants
Covidien LP
Role: Manufacturer
Headquartered in District of Massachusetts; centralization hub for MDL 3029. Facing ~900 federal suits plus Massachusetts state coordination. Ordered Feb. 2024 to produce unredacted complaint files. Bellwether trials scheduled 2025-2026.
Medtronic, Inc.
Role: Parent/Related Corporate Defendant
Named in MDL 3029 transfer order alongside Covidien entities. Corporate disclosure identifies MEDTRONIC plc as parent. Defense posture coordinated with Covidien LP through unified appearance filings.
Sofradim Productions SAS
Role: Manufacturer/Supplier
French entity named in MDL 3029; produces Parietex mesh components. Transferred into D. Mass. with Covidien defendants. Limited separate docket activity; indemnity posture unclear.
| Defendant | Role | Intelligence Note |
|---|---|---|
| Covidien LP | Manufacturer | Headquartered in District of Massachusetts; centralization hub for MDL 3029. Facing ~900 federal suits plus Massachusetts state coordination. Ordered Feb. 2024 to produce unredacted complaint files. Bellwether trials scheduled 2025-2026. |
| Medtronic, Inc. | Parent/Related Corporate Defendant | Named in MDL 3029 transfer order alongside Covidien entities. Corporate disclosure identifies MEDTRONIC plc as parent. Defense posture coordinated with Covidien LP through unified appearance filings. |
| Sofradim Productions SAS | Manufacturer/Supplier | French entity named in MDL 3029; produces Parietex mesh components. Transferred into D. Mass. with Covidien defendants. Limited separate docket activity; indemnity posture unclear. |
Timeline
FDA recalls Parietex Composite Parastomal Mesh
FDA recalls over 7,300 units of Parietex Composite Parastomal Mesh, first major regulatory action on Covidien hernia mesh products.
JPML creates MDL 3029 in D. Mass.
Judicial Panel on Multidistrict Litigation consolidates Covidien hernia mesh cases as MDL 3029, assigned to Judge Patti B. Saris in the U.S. District Court for the District of Massachusetts.
Rule 702 rulings shape expert testimony
Judge Saris issues Daubert opinions allowing certain defense biomaterials testimony to proceed, establishing evidentiary framework for bellwether trials.
Punitive damages allowed in Patterson bellwether
Judge Saris denies bulk of Covidien's summary judgment motion and permits punitive damages claims to proceed, finding sufficient evidence Covidien knowingly misrepresented Symbotex collagen barrier resorption lifespan. Patterson v. Covidien, No. 1:20-cv-12345 (D. Mass.).
First Covidien bellwether trial begins
Patterson v. Covidien opens before Judge Saris in D. Mass., first federal jury trial in MDL 3029. Plaintiff alleges 2017 Symbotex implant caused bowel obstruction requiring resection; 2,400+ cases pending in MDL, 6,000+ in state courts.
Statute of limitations
MDL 3029 (In re: Covidien Hernia Mesh Products Liability Litigation) before Judge Patti B. Saris in D. Mass. does not toll state SOLs. First bellwether trial scheduled July 2026; mediation deadline January 14, 2026. No federal preemption applies to state-law failure-to-warn and design defect claims. Cross-jurisdictional screening requires careful accrual analysis for plaintiffs with revision surgeries in multiple states.
Massachusetts
3 years from discovery
Rule: Mass. Gen. Laws ch. 260, § 2A; discovery rule applies per common law
Discovery: Accrues when plaintiff knew or should have known of injury and its causal link to product
MDL 3029 centralized in D. Mass. before Judge Patti B. Saris. First bellwether trial reset for July 2026. Mediation deadline extended to January 14, 2026. No tolling effect from MDL consolidation—state SOL controls.
California
2 years from discovery
Rule: Cal. Code Civ. Proc. § 335.1; discovery rule codified at § 338
Discovery: Accrues when plaintiff discovers or should have discovered injury and probable cause
Large plaintiff pool. No pending revival statute.
Florida
4 years from discovery
Rule: Fla. Stat. § 95.11(3)(a); discovery rule applies per Tischner v. DH Griffin Wrecking Co., 947 So. 2d 1223 (Fla. 2006)
Discovery: Accrues when plaintiff knew or should have known of injury and defendant's potential liability
Substantial Covidien filings. No current revival window.
New York
3 years from discovery
Rule: N.Y. C.P.L.R. § 214(2); discovery rule applies per LaBarbera v. Morgan, 814 N.Y.S.2d 535 (App. Div. 2006)
Discovery: Accrues when plaintiff discovers or should have discovered injury and its cause
Large volume jurisdiction. No revival legislation pending.
Texas
2 years from discovery
Rule: Tex. Civ. Prac. & Rem. Code § 16.003; discovery rule applies per S.V. v. R.V., 933 S.W.2d 1 (Tex. 1996)
Discovery: Accrues when plaintiff knew or should have known of injury and its cause in fact
Significant plaintiff base. No tolling from MDL 3029.
Pennsylvania
2 years from discovery
Rule: 42 Pa. Cons. Stat. § 5524(2); discovery rule applies per Pocono Int'l Raceway, Inc. v. Pocono Produce, Inc., 468 A.2d 468 (Pa. 1983)
Discovery: Accrues when plaintiff knows or reasonably should know of injury and its cause
Active filing state. No pending revival.
Rhode Island
3 years from discovery of wrongdoing
Rule: R.I. Gen. Laws § 9-1-14(b); extended rule per Anthony v. Abbott Labs., 490 A.2d 43 (R.I. 1985)
Discovery: Accrues when plaintiff discovers or should discover manufacturer's wrongdoing—not merely injury
Anthony rule provides extended accrual theory distinct from standard discovery rule. Applies to product liability generally, not Bard-specific. Forum non conveniens risk for non-residents.
| State | SOL | Rule | Discovery Rule | Notes |
|---|---|---|---|---|
| Massachusetts | 3 years from discovery | Mass. Gen. Laws ch. 260, § 2A; discovery rule applies per common law | Accrues when plaintiff knew or should have known of injury and its causal link to product | MDL 3029 centralized in D. Mass. before Judge Patti B. Saris. First bellwether trial reset for July 2026. Mediation deadline extended to January 14, 2026. No tolling effect from MDL consolidation—state SOL controls. |
| California | 2 years from discovery | Cal. Code Civ. Proc. § 335.1; discovery rule codified at § 338 | Accrues when plaintiff discovers or should have discovered injury and probable cause | Large plaintiff pool. No pending revival statute. |
| Florida | 4 years from discovery | Fla. Stat. § 95.11(3)(a); discovery rule applies per Tischner v. DH Griffin Wrecking Co., 947 So. 2d 1223 (Fla. 2006) | Accrues when plaintiff knew or should have known of injury and defendant's potential liability | Substantial Covidien filings. No current revival window. |
| New York | 3 years from discovery | N.Y. C.P.L.R. § 214(2); discovery rule applies per LaBarbera v. Morgan, 814 N.Y.S.2d 535 (App. Div. 2006) | Accrues when plaintiff discovers or should have discovered injury and its cause | Large volume jurisdiction. No revival legislation pending. |
| Texas | 2 years from discovery | Tex. Civ. Prac. & Rem. Code § 16.003; discovery rule applies per S.V. v. R.V., 933 S.W.2d 1 (Tex. 1996) | Accrues when plaintiff knew or should have known of injury and its cause in fact | Significant plaintiff base. No tolling from MDL 3029. |
| Pennsylvania | 2 years from discovery | 42 Pa. Cons. Stat. § 5524(2); discovery rule applies per Pocono Int'l Raceway, Inc. v. Pocono Produce, Inc., 468 A.2d 468 (Pa. 1983) | Accrues when plaintiff knows or reasonably should know of injury and its cause | Active filing state. No pending revival. |
| Rhode Island | 3 years from discovery of wrongdoing | R.I. Gen. Laws § 9-1-14(b); extended rule per Anthony v. Abbott Labs., 490 A.2d 43 (R.I. 1985) | Accrues when plaintiff discovers or should discover manufacturer's wrongdoing—not merely injury | Anthony rule provides extended accrual theory distinct from standard discovery rule. Applies to product liability generally, not Bard-specific. Forum non conveniens risk for non-residents. |
Live intelligence
AI litigation brief
Covidien Hernia Mesh remains established mass tort / active mdl with 73 current signals in the accepted feed.
Overview
MDL 3029 entered active bellwether phase after an $88 million plaintiff verdict in Patterson v. Covidien, No. 1:22-cv-10153 (D. Mass. Aug. 4, 2026). Judge Patti B. Saris denied Covidien's summary judgment motion on failure-to-warn, negligence, misrepresentation, fraudulent concealment, breach of implied warranty, and punitive damages claims before trial. The court adopted stipulated protective orders and plaintiff fact sheet instructions on Aug. 10, 2026.
Key developments
Trajectory
Court filings and press coverage are both active in MDL 3029, pointing to sustained litigation pressure rather than a one-off headline cycle. 6 live sources are contributing current context.
Editorial intelligence
MDL 3029 should stay on the lead docket watch because it is the primary consolidation vehicle for Covidien Hernia Mesh.
Generated Aug 12, 2026, 2:00 AM UTC
73 events detected
Google News (21)
Medtronic Hit with $88M Verdict in Hernia Mesh Lawsuit - Medical Device and Diagnostic industry
Jury says Medtronic must pay $88M in Covidien hernia mesh suit - MassDevice
Etowah Co. couple awarded $88 million in landmark hernia mesh verdict - WBMA
1st Covidien MDL Bellwether Trial Ends With $88 Million Jury Award - Mealey's
Levin Papantonio Client Awarded $88 Million Verdict in First Federal Covidien Hernia Mesh Bellwether Trial - GlobeNewswire
US jury says Medtronic owes $88 million in first case to go to trial over Covidien’s hernia mesh By Reuters - Investing.com
Medtronic faces $88 million verdict in hernia mesh trial - Investing.com
BREAKING: Bellwether Jury Awards $88M In Covidien Hernia Mesh Trial - law360.com
Bellwether Jury Awards $88M In Covidien Hernia Mesh Trial - law360.com
Medtronic faces $88 million verdict in hernia mesh trial By Investing.com - Investing.com Australia
Medtronic Ordered to Pay $88 Million in First Hernia Mesh Test Trial - Межа. Новини України.
US jury says Medtronic owes $88 million in first case to go to trial over Covidien's hernia mesh - Reuters
An Alabama resident, who is suing Medtronic's Covidien unit over injuries he says were caused by a hernia mesh product, exits the federal courthouse in Boston - The Daily News | Texas' Oldest Newspaper
Covidien Hid Mesh Risks, Bellwether Jury Told As Trial Ends - law360.com
With 10,000 lawsuits pending, Medtronic’s hernia mesh faces its first jury - Star Tribune
Medtronic faces first trial in US hernia mesh injury cases - Reuters
Covidien Hid Mesh Risk From Doctors, Bellwether Jury Told - Law360
Medtronic Unit Must Face Bellwether Hernia Mesh Claims - Law360
Covidien MDL Judge Largely Denies Summary Judgment In 1st Bellwether Case - Mealey's
Outer House grants permission for hernia mesh group proceedings - Scottish Legal News
Court clears path for Scottish hernia mesh group action - ICLG
No recent PubMed signals. Monitoring is active — this section updates automatically.
Covidien Hernia Mesh Products Liability Litigation (No. II)
PACER docket filed in JPML: The plaintiffs claim that Covidien LP and Sofradim Production SAS produced and sold defective hernia mesh devices, leading to injuries related to their defective nature. The involved products include Dextile Anatomical Mesh, Parietene DS Mesh, Parietene Polypropylene Mesh, among others. The lawsuit
Plaintiff Fact Sheet Instructions
mad_html
Order requiring plaintiffs to complete and submit a Plaintiff Fact Sheet (PFS) for each individual plaintiff in the MDL, with definitions and instructions.
Protective Order — Stipulated Protective Order Adopted
mad_html
The court adopts the stipulated protective order with modifications, governing the use and designation of confidential discovery materials in the MDL.
Covidien Hernia Mesh Products Liability Litigation (No. II)
PACER docket entry from MAD: COMPLAINT against All Defendants Filing fee: $ 405, receipt number AMADC-11949746 (Fee Status: Filing Fee paid), filed by Margaret Murphy. (Attachments: # 1 Civil Cover Sheet)(DeFrance-Poindexter, Syreeta) (Entered: 08/10/2026)
Covidien Hernia Mesh Products Liability Litigation (No. II)
PACER docket entry from MAD: COMPLAINT against All Defendants Filing fee: $ 405, receipt number AMADC-11949725 (Fee Status: Filing Fee paid), filed by Martin Sauceda. (Attachments: # 1 Civil Cover Sheet)(DeFrance-Poindexter, Syreeta) (Entered: 08/10/2026)
Covidien Hernia Mesh Products Liability Litigation (No. II)
PACER docket entry from MAD: COMPLAINT against All Defendants Filing fee: $ 405, receipt number AMADC-11949661 (Fee Status: Filing Fee paid), filed by Pamela Learn. (Attachments: # 1 Civil Cover Sheet)(DeFrance-Poindexter, Syreeta) (Entered: 08/10/2026)
Covidien Hernia Mesh Products Liability Litigation (No. II)
PACER docket entry from MAD: COMPLAINT against All Defendants Filing fee: $ 405, receipt number AMADC-11949626 (Fee Status: Filing Fee paid), filed by Patricia Mitchell. (Attachments: # 1 Civil Cover Sheet)(DeFrance-Poindexter, Syreeta) (Entered: 08/10/2026)
Covidien Hernia Mesh Products Liability Litigation (No. II)
PACER docket entry from MAD: COMPLAINT against All Defendants Filing fee: $ 405, receipt number AMADC-11949595 (Fee Status: Filing Fee paid), filed by Patricia Regula. (Attachments: # 1 Civil Cover Sheet)(DeFrance-Poindexter, Syreeta) (Entered: 08/10/2026)
Covidien Hernia Mesh Products Liability Litigation (No. II)
PACER docket entry from MAD: COMPLAINT against All Defendants Filing fee: $ 405, receipt number AMADC-11949555 (Fee Status: Filing Fee paid), filed by Scott Mowry. (Attachments: # 1 Civil Cover Sheet)(DeFrance-Poindexter, Syreeta) (Entered: 08/10/2026)
Covidien Hernia Mesh Products Liability Litigation (No. II)
PACER docket entry from MAD: COMPLAINT against All Defendants Filing fee: $ 405, receipt number AMADC-11949491 (Fee Status: Filing Fee paid), filed by William Albion. (Attachments: # 1 Civil Cover Sheet)(DeFrance-Poindexter, Syreeta) (Entered: 08/10/2026)
Workbench
Sign in to save litigations, capture notes, and monitor live signals. Sign in for unlimited.
LexGenius Ranking
96Score
Court, news, and regulatory activity are elevated
Monitoring
Live
monitoring
Last: Aug 12, 2026, 2:00 AM UTC
Next: —
Source Monitoring
PACER
PACER
Google News
MAUDE
PubMed
Event feed
73
events detected
AI Brief
Covidien Hernia Mesh remains established mass tort / active mdl with 73 current signals in the accepted feed.
Overview
MDL 3029 entered active bellwether phase after an $88 million plaintiff verdict in Patterson v. Covidien, No. 1:22-cv-10153 (D. Mass. Aug. 4, 2026). Judge Patti B. Saris denied Covidien's summary judgment motion on failure-to-warn, negligence, misrepresentation, fraudulent concealment, breach of implied warranty, and punitive damages claims before trial. The court adopted stipulated protective orders and plaintiff fact sheet instructions on Aug. 10, 2026.
Key developments
PACER court filing on Dec 31: Covidien Hernia Mesh Products Liability Litigation (No. II). ‖ Medical Device and Diagnostic industry news on Aug 5: Medtronic Hit with $88M Verdict in Hernia Mesh Lawsuit - Medical Device and Diagnostic industry. ‖ MAUDE FDA alert on Jul 31: MAUDE Filing 50107550: Progrip.
Generated Aug 12, 2026, 2:00 AM UTC
Tracked MDLs
MDL 3029
D. Mass.
Covidien/Parietex hernia mesh